COGNEX CORP·4

Feb 24, 4:29 PM ET

Kuechen Joerg 4

4 · COGNEX CORP · Filed Feb 24, 2026

Research Summary

AI-generated summary of this filing

Updated

Cognex (CGNX) Head of M&A Joerg Kuechen Exercises Options, Sells Shares

What Happened

  • Joerg Kuechen, Head of Corporate M&A at Cognex (CGNX), exercised stock options and had restricted stock units vest, acquiring 70,851 shares in total on Feb 20–21, 2026. He sold 61,900 of those shares in open-market transactions for total cash proceeds of $3,468,387 and had 5,648 shares withheld to satisfy tax withholding obligations (valued at $316,457). Net shares retained from these transactions: 3,303.
  • The exercised option lots (cash paid at exercise) were: 11,029 shares @ $33.04 ($364,398), 12,500 @ $38.39 ($479,875), and 35,642 @ $39.44 ($1,405,720) — aggregate exercise cost ~$2.25M. Sales were at prices between $55.98–$56.24, indicating immediate sale of most acquired shares (i.e., effectively a cashless exercise).

Key Details

  • Transaction dates: Feb 20–21, 2026; Form 4 filed Feb 24, 2026 (within the standard two-business-day reporting window).
  • Open-market sales: 11,029 @ $55.98 ($617,405); 12,500 @ $56.03 ($700,403); 35,642 @ $56.03 ($1,997,100); 2,729 @ $56.24 ($153,479). Total = $3,468,387.
  • Tax withholding (shares withheld): 2,575 @ $56.03 ($144,277) and 3,073 @ $56.03 ($172,180). Total value = $316,457 (footnotes F1, F2).
  • Shares acquired via exercise/vesting: 70,851 total (includes option exercises and vested RSUs reported at $0 exercise price for RSUs).
  • Net shares retained from these events: 3,303.
  • Relevant footnotes: F1–F2 = shares withheld for tax on RSUs that vested Feb 20/21, 2026; F3–F5 = option vesting schedules; F6–F8 = RSU definitions and vesting schedules.
  • Transaction codes: M = option exercise/conversion, S = open-market sale, F = shares withheld to satisfy tax obligations.

Context

  • This is primarily an exercise + sell transaction (often a cashless exercise): Kuechen exercised options and/or received vested RSUs, sold most of the resulting shares to cover exercise costs and taxes, and retained a small residual position.
  • Such insider sales are frequently routine (to cover tax/exercise costs) and do not by themselves indicate a change in sentiment about the company.

Insider Transaction Report

Form 4
Period: 2026-02-20
Kuechen Joerg
Head of Corporate M&A
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-20$33.04/sh+11,029$364,39813,758 total
  • Sale

    Common Stock

    2026-02-20$55.98/sh11,029$617,4052,729 total
  • Exercise/Conversion

    Common Stock

    2026-02-20$38.39/sh+12,500$479,87515,229 total
  • Sale

    Common Stock

    2026-02-20$56.03/sh12,500$700,4032,729 total
  • Exercise/Conversion

    Common Stock

    2026-02-20$39.44/sh+35,642$1,405,72038,371 total
  • Sale

    Common Stock

    2026-02-20$56.03/sh35,642$1,997,1002,729 total
  • Sale

    Common Stock

    2026-02-20$56.24/sh2,729$153,4790 total
  • Exercise/Conversion

    Common Stock

    2026-02-20+5,3255,325 total
  • Tax Payment

    Common Stock

    [F1]
    2026-02-20$56.03/sh2,575$144,2772,750 total
  • Exercise/Conversion

    Common Stock

    2026-02-21+6,3559,105 total
  • Tax Payment

    Common Stock

    [F2]
    2026-02-21$56.03/sh3,073$172,1806,032 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F3]
    2026-02-2011,02944,112 total
    Exercise: $33.04From: 2026-02-18Exp: 2035-02-18Common Stock (11,029 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F4]
    2026-02-2012,5000 total
    Exercise: $38.39From: 2018-02-21Exp: 2027-02-21Common Stock (12,500 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F5]
    2026-02-2035,64253,461 total
    Exercise: $39.44From: 2025-02-20Exp: 2034-02-20Common Stock (35,642 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F6][F7]
    2026-02-216,3550 total
    Exercise: $0.00From: 2024-02-21Exp: 2026-02-21Common Stock (6,355 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    [F6][F8]
    2026-02-205,3258,874 total
    Exercise: $0.00From: 2025-02-20Exp: 2027-02-20Common Stock (5,325 underlying)
Holdings
  • Non-Qualified Stock Option (right to buy)

    Exercise: $47.21From: 2024-02-21Exp: 2033-02-21Common Stock (67,759 underlying)
    67,759
  • Non-Qualified Stock Option (right to buy)

    Exercise: $47.95From: 2026-08-04Exp: 2032-08-04Common Stock (39,894 underlying)
    39,894
  • Non-Qualified Stock Option (right to buy)

    Exercise: $50.94From: 2021-02-18Exp: 2030-02-18Common Stock (80,000 underlying)
    80,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $51.49From: 2020-02-19Exp: 2029-02-19Common Stock (45,000 underlying)
    45,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $56.44From: 2019-02-20Exp: 2028-02-20Common Stock (30,000 underlying)
    30,000
  • Non-Qualified Stock Option (right to buy)

    Exercise: $64.43From: 2023-02-22Exp: 2032-02-22Common Stock (49,530 underlying)
    49,530
  • Non-Qualified Stock Option (right to buy)

    Exercise: $90.50From: 2022-02-16Exp: 2031-02-16Common Stock (29,486 underlying)
    29,486
  • Restricted Stock Unit

    Exercise: $0.00From: 2028-02-17Exp: 2028-02-17Common Stock (8,759 underlying)
    8,759
  • Restricted Stock Unit

    Exercise: $0.00From: 2026-02-18Exp: 2028-02-18Common Stock (16,223 underlying)
    16,223
Footnotes (8)
  • [F1]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein.
  • [F2]This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein.
  • [F3]The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
  • [F4]The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 21, 2017).
  • [F5]The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024).
  • [F6]Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
  • [F7]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
  • [F8]The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.
Signature
Joerg Kuechen|2026-02-24

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT